Compile Data Set for Download or QSAR
maximum 50k data
Found 34 Enz. Inhib. hit(s) with all data for entry = 6455
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM130255(US8815852, 95)
Affinity DataIC50:  5.82nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM50393658(CHEMBL2158721 | US8815852, 39)
Affinity DataIC50:  12.6nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM7011(US8815852, 96)
Affinity DataIC50:  20.4nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM50393659(CHEMBL2158720 | US8815852, 36)
Affinity DataIC50:  61.5nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM50393655(CHEMBL2158725 | US8815852, 21)
Affinity DataIC50:  64.5nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM50393660(CHEMBL2158719 | US8815852, 26)
Affinity DataIC50:  80.8nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM130254(US8815852, 94)
Affinity DataIC50:  89.8nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM50393659(CHEMBL2158720 | US8815852, 36)
Affinity DataIC50:  93.8nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM50393661(CHEMBL2158718 | US8815852, 27)
Affinity DataIC50:  97.6nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM50393663(CHEMBL2158716 | US8815852, 41)
Affinity DataIC50:  110nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM130250(US8815852, 1)
Affinity DataIC50:  139nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM50393663(CHEMBL2158716 | US8815852, 41)
Affinity DataIC50:  160nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM50393661(CHEMBL2158718 | US8815852, 27)
Affinity DataIC50:  164nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM7043(US8815852, 97)
Affinity DataIC50:  181nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM50393654(CHEMBL2158726 | US8815852, 22)
Affinity DataIC50:  264nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM130252(US8815852, 25)
Affinity DataIC50:  338nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM130250(US8815852, 1)
Affinity DataIC50:  434nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM130252(US8815852, 25)
Affinity DataIC50:  448nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM50393660(CHEMBL2158719 | US8815852, 26)
Affinity DataIC50:  502nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM130254(US8815852, 94)
Affinity DataIC50:  514nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM7043(US8815852, 97)
Affinity DataIC50:  519nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM50393658(CHEMBL2158721 | US8815852, 39)
Affinity DataIC50:  660nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM130253(US8815852, 93)
Affinity DataIC50:  940nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM50393655(CHEMBL2158725 | US8815852, 21)
Affinity DataIC50:  1.05E+3nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM130255(US8815852, 95)
Affinity DataIC50:  1.50E+3nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM50393654(CHEMBL2158726 | US8815852, 22)
Affinity DataIC50:  1.86E+3nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM50393656(CHEMBL2158723 | US8815852, 16)
Affinity DataIC50:  2.05E+3nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM7060(US8815852, 102)
Affinity DataIC50:  2.78E+3nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM7011(US8815852, 96)
Affinity DataIC50:  3.14E+3nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM7060(US8815852, 102)
Affinity DataIC50:  4.31E+3nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM130251(US8815852, 20)
Affinity DataIC50:  5.85E+3nMpH: 7.7 T: 2°CAssay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM50393656(CHEMBL2158723 | US8815852, 16)
Affinity DataIC50:  6.57E+3nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM130253(US8815852, 93)
Affinity DataIC50:  1.00E+4nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM130251(US8815852, 20)
Affinity DataIC50:  1.98E+4nMpH: 7.4Assay Description:6-week-old Sprague-Dawley (SD) rats were anesthetized in an ether container for 5 minutes, brains were separated from rats, and cortical regions were...More data for this Ligand-Target Pair
In DepthDetails US Patent